Rouen, France

Philippe Picart

This inventor holds 1 USPTO granted patent. Top assignee: Choay, S.a.. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Philippe Picart: Innovator in Pharmaceutical Technology

Introduction

Philippe Picart is a notable inventor based in Rouen, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of purified heparin fractions. His innovative work has implications for medical treatments and drug formulations.

Latest Patents

Philippe Picart holds a patent for "Purified heparin fractions, method for obtaining them and pharmaceutical." This patent describes heparin fractions obtained by nitrous depolymerization, which contain at most 150 ppb of total N-nitroso compounds. The method involves subjecting natural heparins that have been depolymerized with a nitrite to the action of UV radiation. This innovative approach enhances the safety and efficacy of heparin in pharmaceutical applications.

Career Highlights

Philippe Picart is associated with Choay, S.A., a company known for its advancements in pharmaceutical products. His work has contributed to the company's reputation for innovation in the field. With a focus on improving drug safety, Picart's research has paved the way for new methodologies in heparin production.

Collaborations

Philippe has collaborated with notable colleagues such as Jos E Espejo and Jean-Francedillaois Branellec. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.

Conclusion

Philippe Picart's contributions to the field of pharmaceutical technology through his patent on purified heparin fractions demonstrate his commitment to innovation and safety in medicine. His work continues to influence the industry and improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…